Marchand Salomé, Morel-Journel Nicolas, Carnicelli Damien, Boucher Fabien, Ruffion Alain, Neuville Paul
Urology Department, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Lyon, France.
Urology Department, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Lyon, France; Université Claude Bernard Lyon, Lyon, France.
Urology. 2025 Apr;198:217-221. doi: 10.1016/j.urology.2025.01.002. Epub 2025 Jan 9.
To report the surgical outcomes and complications experienced after implantation of the ZSI475 FtM prosthesis after phalloplasty.
All consecutive patients who underwent ZSI475FtM prosthesis implantation in their neophallus between January 2016 and March 2024 in our center were included. There was no exclusion criterion. We considered the occurrence of a complication according to the date of first appearance in the medical record.
A total of 89 patients, accounting for 130 implantation surgeries, were included. Among the 130 implantations, 69 (53.1%) led to a complication; the most frequent was mechanical dysfunction (52/130, 40.0%), followed by infection (8/130, 6.2%), malposition (7/130, 5.4%), and erosion (2/130, 1.5%). All cases of infection and erosion were treated by prosthesis removal. Overall, these complications led to 60 revision surgeries for replacement (41/60, 68.3%), removal (17/60, 28.3%), and refixation (2/60, 3.3%). The median follow-up was 3.9years [IQR, 2.3-5.5], and the median time to complication was 1.6years [IQR, 0.4-2.4]. The median survival time of the prosthesis was 5.4years [IQR, 4.6-5.9] and the 4-year probability of survival was 74.0% (95%CI [65.6-83.4]).
The ZSI475 FtM implant shows a survival probability similar to the rates reported in the literature. Future improvements are needed to increase its robustness and survival. The next step toward a better understanding of the associated complications will involve multicenter data collection of the surgical outcomes.
报告阴茎成形术后植入ZSI475 FtM假体后的手术结果及并发症。
纳入2016年1月至2024年3月在本中心新阴茎中连续接受ZSI475 FtM假体植入的所有患者。无排除标准。我们根据病历中首次出现的日期判断并发症的发生情况。
共纳入89例患者,计130次植入手术。在130次植入中,69例(53.1%)出现并发症;最常见的是机械功能障碍(52/130,40.0%),其次是感染(8/130,6.2%)、位置异常(7/130,5.4%)和侵蚀(2/130,1.5%)。所有感染和侵蚀病例均通过取出假体进行治疗。总体而言,这些并发症导致60次翻修手术,包括更换(41/60,68.3%)、取出(17/60,28.3%)和重新固定(2/60,3.3%)。中位随访时间为3.9年[四分位间距,2.3 - 5.5],并发症出现的中位时间为1.6年[四分位间距,0.4 - 2.4]。假体的中位生存时间为5.4年[四分位间距,4.6 - 5.9],4年生存概率为74.0%(95%置信区间[65.6 - 83.4])。
ZSI475 FtM植入物的生存概率与文献报道的率相似。未来需要改进以提高其耐用性和生存率。更好地了解相关并发症的下一步将涉及多中心收集手术结果数据。